Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Deficit in Schizophrenia”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Not applicableNot Yet RecruitingNCT07506070
What this trial is testing

Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital

Who this might be right for
Psychiatric DisordersDepression - Major Depressive DisorderSchizophrenia and Other Psychotic Disorders+4 more
The Royal Ottawa Mental Health Centre 160
Large-scale testing (Phase 3)Study completedNCT00237809
What this trial is testing

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Yale University 104
Testing effectiveness (Phase 2)Study completedNCT00817336
What this trial is testing

Biomarkers in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Nathan Kline Institute for Psychiatric Research 16
Not applicableStudy completedNCT02976077
What this trial is testing

RC2S+: Remediation of Social Cognitive Impairments

Who this might be right for
Schizophrenia
Hôpital le Vinatier 50
Not applicableNot Yet RecruitingNCT06471179
What this trial is testing

Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments

Who this might be right for
SchizophreniaCognitive Impairment
Assiut University 40
Large-scale testing (Phase 3)UnknownNCT00141947
What this trial is testing

Bexarotene Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 15
Not applicableUnknownNCT05597579
What this trial is testing

Cognitive Impairments in Psychotic Disorders

Who this might be right for
Psychotic DisordersCognitive Impairment
Sheba Medical Center 200
Post-approval studies (Phase 4)Study completedNCT00182442
What this trial is testing

Cognition, Functioning and Quality of Life

Who this might be right for
Schizophrenia
Hamilton Health Sciences Corporation 80
Not applicableNot Yet RecruitingNCT07445620
What this trial is testing

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia

Who this might be right for
PsychosisSchizophrenia Disorder
All India Institute of Medical Sciences, Bhubaneswar 90
Testing effectiveness (Phase 2)Study completedNCT00506077
What this trial is testing

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Who this might be right for
Paranoid Schizophrenia
Merck Sharp & Dohme LLC 55
Early research (Phase 1)Study completedNCT01116830
What this trial is testing

The Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder

Who this might be right for
Schizophrenia
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT03745820
What this trial is testing

Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Biogen 195
Not applicableStudy completedNCT04870996
What this trial is testing

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Who this might be right for
Schizophrenia
CHAN SAU MAN, SANDRA 44
Testing effectiveness (Phase 2)Study completedNCT03557931
What this trial is testing

Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Who this might be right for
Schizophrenia
Astellas Pharma Global Development, Inc. 233
Not applicableStudy completedNCT02360813
What this trial is testing

Cognitive Remediation Therapy Within a Secure Forensic Setting

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Deficits
Central Mental Hospital 65
Early research (Phase 1)Study completedNCT00937846
What this trial is testing

Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study

Who this might be right for
Cognitive Disorders
GlaxoSmithKline 4
Testing effectiveness (Phase 2)Ended earlyNCT05182476
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 216
Testing effectiveness (Phase 2)Looking for participantsNCT07191483
What this trial is testing

Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Kynexis B.V. 150
Not applicableStudy completedNCT03768674
What this trial is testing

Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway

Who this might be right for
Self HarmPersonality DisordersPsychosis+3 more
Oslo University Hospital 1,640
Testing effectiveness (Phase 2)Study completedNCT00505076
What this trial is testing

Treatment Study for Cognitive Deficits in Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 63
Next Page